Yes, semaglutide from Novo Nordisk is FDA-approved to help people with chronic weight management and related medical problems
Cellular repair and regeneration
Semaglutide may be appropriate for: Patients beginning their first medically supervised weight loss program Individuals who want established, gradual GLP-1 support with physician-guided dosing Patients focused on appetite control and long-term consistency People looking for a convenient telehealth weight loss program Your physician will review your health history and confirm semaglutide is appropriate for you
Addressing emotional eating, stress management, and sleep optimization (hypothyroid patients often experience sleep disturbances) provides comprehensive care
If you notice weakened appetite suppression, slower weight loss trajectory, or reduced satiety compared to earlier doses despite consistent technique, your medication's effectiveness may have declined from storage problems
Semaglutide sends signals to the brain that the stomach is full, so people dont feel as hungry, and it changes the way the brain reacts to food rewards, says Busis, who says they are sometimes used in tandem with CBT